1-3 of 3
William Hahne, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

Maro N. Ohanian, DO, Tara L Lin, MD, Ellen K. Ritchie, MD, Michael Craig, MD, Apurv Agrawal, MD, Kathleen G. Halka, MD, Vinit Karur, MD, Naveen Pemmaraju, MD, Gautam Borthakur, MD, Sarah Aminov, Miranda Lim, BSN, Sherry A. Pierce, BSN, BA, Natalie Sacarakis, Stacy Minor, Ana Tari Ashizawa, PhD, William Hahne, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Gail J. Roboz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1387.
https://doi.org/10.1182/blood-2018-99-113693
Published: 2018
Journal Articles

Phase I Trial of CG53135-05 to Prevent Mucositis in Patients Undergoing High-Dose Chemotherapy (HDCT) and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Michael W. Schuster, MD, Tsiporah B. Shore, MD, June Greenberg, RN, Bita Jalilizeinali, RNP, Scott Possley, Vincent I. Annino, William Hahne, MD
Journal: Blood
Blood (2004) 104 (11): 1161.
https://doi.org/10.1182/blood.V104.11.1161.1161
Published: 2004
Journal Articles

Safety, Tolerability, and Pharmacokinetic Assessment of CG53135 Administered Intravenously in Patients with Advanced (Stage 4) Cancer (Single Rising-Dose Tolerance).

Joe Stephenson, MD, Sanjay Goel, MD, Pankaj Bhargava, MD, Saroj Vadhan-Raj, MD, Vincent Annino, Thomas Hawthorne, PhD, Yuan-Di Halvorsen, PhD, William Hahne, MD
Journal: Blood
Blood (2004) 104 (11): 5030.
https://doi.org/10.1182/blood.V104.11.5030.5030
Published: 2004